Exelixis (EXEL) Tops Q3 EPS by 9c, provides guidance
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $54.08 +0.73%
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.78, $0.09 better than the analyst estimate of $0.69. Revenue for the quarter came in at $597.8 million versus the consensus estimate of $590.47 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.3-2.35 billion, versus the consensus of $2.319 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Myriad Uranium completes acquisition of Rush Rare Metals
- Sigma Lithium resumes full operations after signing TAC agreement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
